CircREOS suppresses lipid synthesis and osteosarcoma progression through inhibiting HuR-mediated MYC activation

Tong, Weilai; Wang, Shijiang; He, Cheng; Li, Anan; Nie, Jiangbo; Zuo, Wei; Yang, Feng; Liu, Zhili

doi:10.7150/jca.83106



International Journal of Biological Sciences

International Journal of Medical Sciences

Theranostics

Journal of Genomics

Nanotheranostics

Global reach, higher impact

Full Text | PDF

J Cancer 2023; 14(6):916-926. doi:10.7150/jca.83106 This issue Cite

Research Paper

CircREOS suppresses lipid synthesis and osteosarcoma progression through inhibiting HuR-mediated MYC activation

Weilai Tong^1,2*, Shijiang Wang^1,2*, Cheng He³, Anan Li^1,2, Jiangbo Nie^1,2, Wei Zuo^1,2, Feng Yang^1,2✉, Zhili Liu^1,2✉

1. Medical Innovation Center, The First Affiliated Hospital of Nanchang University, Jiangxi Medical College of Nanchang University, Nanchang, 330006, People's Republic of China.
2. Department of Orthopedic Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, People's Republic of China.
3. Department of Orthopedics, the 908th Hospital of Joint Logistics Support Forces of Chinese PLA, Nanchang, 330006, People's Republic of China.
^* Equal contribution and Co-first authors.

Citation:

Tong W, Wang S, He C, Li A, Nie J, Zuo W, Yang F, Liu Z. CircREOS suppresses lipid synthesis and osteosarcoma progression through inhibiting HuR-mediated MYC activation. J Cancer 2023; 14(6):916-926. doi:10.7150/jca.83106. https://www.jcancer.org/v14p0916.htm

Other styles

Abstract

MYC proto-oncogene (MYC) is a transcription factor among the most commonly activated oncoproteins, playing vital roles in lipid metabolism and tumor aggressiveness with broad effects. However, it is still largely unknown about the regulating mechanisms of MYC in osteosarcoma (OS). In this study, we identify a circRNA with Reduced Expression in OS (termed as circREOS) generated from MYC gene, as a novel regulator of MYC and OS progression. CircREOS is down-regulated in OS cells and localized in the nucleus. CircREOS suppresses MYC expression, lipid metabolism and growth, invasion in OS cells. Mechanically, circREOS physically interacts with HuR (human antigen R) protein, and subsequently restrains its binding and activation on the 3'-UTR (untranslated region) of MYC mRNA, resulting in down-regulation of MYC and inhibition of OS. Moreover, circREOS serves as a tumor suppressor via targeting lipid metabolism. CircREOS reduces FASN expression and lipid accumulation through inhibiting MYC-facilitated FASN regulation. Taken together, these results indicate that circREOS suppress lipid synthesis and OS progression through inhibiting HuR-mediated MYC activation, providing a potential therapeutic target for OS.

Keywords: MYC, Osteosarcoma, circREOS, HuR, lipid metabolism

Citation styles

APA

Tong, W., Wang, S., He, C., Li, A., Nie, J., Zuo, W., Yang, F., Liu, Z. (2023). CircREOS suppresses lipid synthesis and osteosarcoma progression through inhibiting HuR-mediated MYC activation. Journal of Cancer, 14(6), 916-926. https://doi.org/10.7150/jca.83106.

ACS

Tong, W.; Wang, S.; He, C.; Li, A.; Nie, J.; Zuo, W.; Yang, F.; Liu, Z. CircREOS suppresses lipid synthesis and osteosarcoma progression through inhibiting HuR-mediated MYC activation. J. Cancer 2023, 14 (6), 916-926. DOI: 10.7150/jca.83106.

NLM

CSE

Tong W, Wang S, He C, Li A, Nie J, Zuo W, Yang F, Liu Z. 2023. CircREOS suppresses lipid synthesis and osteosarcoma progression through inhibiting HuR-mediated MYC activation. J Cancer. 14(6):916-926.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.